Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C034008 |
11-deoxyprostaglandin E1 |
11-deoxyprostaglandin E1 binds to and results in increased activity of PTGER4 protein | affects binding|increases activity | 11595431
|
C487890 |
4-(4-cyano-2-(2-(4-fluoronaphthalen-1-yl)propionylamino)phenyl)butyric acid |
4-(4-cyano-2-(2-(4-fluoronaphthalen-1-yl)propionylamino)phenyl)butyric acid results in decreased activity of PTGER4 protein | decreases activity | 15976003
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of PTGER4 mRNA | affects expression | 16483693
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of PTGER4 mRNA | affects expression | 20382639
|
C095105 |
bexarotene |
bexarotene results in decreased expression of PTGER4 mRNA | decreases expression | 17849452
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of PTGER4 mRNA | increases expression | 20096755
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of PTGER4 mRNA | affects expression | 17484886
|
D003993 |
Dibutyl Phthalate |
Dibutyl Phthalate results in decreased expression of PTGER4 mRNA | decreases expression | 15620428
|
C036042 |
dicyclohexyl phthalate |
dicyclohexyl phthalate results in increased expression of PTGER4 mRNA | increases expression | 15620428
|
D004051 |
Diethylhexyl Phthalate |
Diethylhexyl Phthalate results in decreased expression of PTGER4 mRNA | decreases expression | 15620428
|
D002117 |
Calcitriol |
Calcitriol results in decreased expression of PTGER4 mRNA | decreases expression | 16002434
|
D015064 |
16,16-Dimethylprostaglandin E2 |
16,16-Dimethylprostaglandin E2 binds to and results in increased activity of PTGER4 protein | affects binding|increases activity | 11595431
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of PTGER4 mRNA | affects cotreatment|increases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in increased expression of PTGER4 mRNA | increases expression | 19619570 19153601
|
D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in increased expression of PTGER4 mRNA | affects cotreatment|increases expression | 15829624
|
D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in increased expression of PTGER4 protein | affects cotreatment|increases expression | 15829624
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of PTGER4 mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of PTGER4 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PTGER4 mRNA | affects cotreatment|increases expression | 17942748
|
D005665 |
Furosemide |
PTGER4 protein affects the reaction [Furosemide results in increased expression of REN mRNA] | affects reaction|increases expression | 15976003
|
D005665 |
Furosemide |
PTGER4 protein affects the reaction [Furosemide results in increased expression of REN protein] | affects reaction|increases expression | 15976003
|
C029424 |
hydrazine |
hydrazine results in decreased expression of PTGER4 mRNA | decreases expression | 15282401
|
C475919 |
hydroxytamoxifen |
GPR30 protein affects the reaction [hydroxytamoxifen results in increased expression of PTGER4 mRNA] | affects reaction|increases expression | 19153601
|
C475919 |
hydroxytamoxifen |
hydroxytamoxifen results in increased expression of PTGER4 mRNA | increases expression | 19153601
|
C119620 |
kenpaullone |
kenpaullone results in decreased expression of PTGER4 mRNA | decreases expression | 17993264
|
D015741 |
Metribolone |
Metribolone results in increased expression of PTGER4 mRNA | increases expression | 17010675
|
C528911 |
N-((4-(5,9-diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo(3,4-g)quinolin-7-yl)-3-methylbenzyl)sulfonyl)-2-(2-methoxyphenyl)acetamide |
N-((4-(5,9-diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo(3,4-g)quinolin-7-yl)-3-methylbenzyl)sulfonyl)-2-(2-methoxyphenyl)acetamide binds to and results in decreased activity of PTGER4 protein | affects binding|decreases activity | 18287210
|
C528911 |
N-((4-(5,9-diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo(3,4-g)quinolin-7-yl)-3-methylbenzyl)sulfonyl)-2-(2-methoxyphenyl)acetamide |
N-((4-(5,9-diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo(3,4-g)quinolin-7-yl)-3-methylbenzyl)sulfonyl)-2-(2-methoxyphenyl)acetamide results in decreased expression of PTGER4 mRNA | decreases expression | 18287210
|
C025256 |
nonylphenol |
nonylphenol results in decreased expression of PTGER4 mRNA | decreases expression | 15620428
|
C461399 |
ONO-AE1-329 |
PTGER4 protein affects the reaction [ONO-AE1-329 inhibits the reaction [Zymosan results in increased expression of TNF mRNA]] | affects reaction|decreases reaction|increases expression | 11301049
|
C461399 |
ONO-AE1-329 |
PTGER4 protein affects the reaction [ONO-AE1-329 inhibits the reaction [Zymosan results in increased expression of TNF protein]] | affects reaction|decreases reaction|increases expression | 11301049
|
C461399 |
ONO-AE1-329 |
PTGER4 protein affects the reaction [ONO-AE1-329 promotes the reaction [Zymosan results in increased expression of IL10 mRNA]] | affects reaction|increases expression|increases reaction | 11301049
|
C461399 |
ONO-AE1-329 |
PTGER4 protein affects the reaction [ONO-AE1-329 promotes the reaction [Zymosan results in increased expression of IL10 protein]] | affects reaction|increases expression|increases reaction | 11301049
|
C461399 |
ONO-AE1-329 |
ONO-AE1-329 binds to and results in increased activity of PTGER4 protein | affects binding|increases activity | 11595431
|
D017239 |
Paclitaxel |
Paclitaxel results in decreased expression of PTGER4 mRNA | decreases expression | 15585946
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of PTGER4 mRNA | decreases expression | 17426115
|
C009042 |
pristane |
pristane results in increased expression of PTGER4 mRNA | increases expression | 15075356
|
D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in increased expression of PTGER4 mRNA | affects cotreatment|increases expression | 15829624
|
D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in increased expression of PTGER4 protein | affects cotreatment|increases expression | 15829624
|
D015232 |
Dinoprostone |
Dinoprostone binds to and results in decreased activity of PTGER4 protein | affects binding|decreases activity | 12009843
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of PTGER4 mRNA | decreases expression | 16014739
|
D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of PTGER4 mRNA | increases expression | 18175754
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of PTGER4 mRNA | affects expression | 17555576
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of PTGER4 mRNA | affects cotreatment|increases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of PTGER4 mRNA | increases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PTGER4 mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of PTGER4 mRNA | increases expression | 17942748
|
C017963 |
vinyl carbamate |
vinyl carbamate results in decreased expression of PTGER4 mRNA | decreases expression | 17849452
|
D015054 |
Zymosan |
PTGER4 protein affects the reaction [ONO-AE1-329 inhibits the reaction [Zymosan results in increased expression of TNF mRNA]] | affects reaction|decreases reaction|increases expression | 11301049
|
D015054 |
Zymosan |
PTGER4 protein affects the reaction [ONO-AE1-329 inhibits the reaction [Zymosan results in increased expression of TNF protein]] | affects reaction|decreases reaction|increases expression | 11301049
|
D015054 |
Zymosan |
PTGER4 protein affects the reaction [ONO-AE1-329 promotes the reaction [Zymosan results in increased expression of IL10 mRNA]] | affects reaction|increases expression|increases reaction | 11301049
|
D015054 |
Zymosan |
PTGER4 protein affects the reaction [ONO-AE1-329 promotes the reaction [Zymosan results in increased expression of IL10 protein]] | affects reaction|increases expression|increases reaction | 11301049
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.22 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Diethylhexyl Phthalate |
7.63 | 6734493 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.63 | 11752688 15322242 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.23 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.61 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.82 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
6.73 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
6.73 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
vinyl carbamate |
6.73 | 16247444 17363558 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
15.62 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
15.62 | 16835633 |
MESH:D018248 |
Adenoma, Liver Cell |
|
vinyl carbamate |
15.62 | 12371669 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
Dinoprostone |
4.75 | 17942926 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.37 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.57 | 16712894 17306315 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
8.06 | 11748828 |
MESH:D000740 |
Anemia |
|
Zymosan |
8.06 | 18664788 |
MESH:D001014 |
Aortic Aneurysm |
|
Dinoprostone |
5.30 | 10231640 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Dinoprostone |
5.31 | 10388637 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.15 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
marker/mechanism |
|
| 18287210 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
11.54 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
N-((4-(5,9-diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo(3,4-g)quinolin-7-yl)-3-methylbenzyl)sulfonyl)-2-(2-methoxyphenyl)acetamide |
11.54 | 18287210 |
MESH:D001169 |
Arthritis, Experimental |
|
Zymosan |
11.54 | 16872482 15142272 15188379 17659584 15944321 |
MESH:D001477 |
Bartter Syndrome |
|
Dinoprostone |
5.42 | 15976003 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
7.80 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
7.80 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.46 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.56 | 15746008 |
MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
4.27 | 15867366 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.57 | 11985600 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.01 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
3.94 | 15845082 15665606 15380490 |
MESH:D001943 |
Breast Neoplasms |
|
bexarotene |
4.44 | 16344269 16818667 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
4.44 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
4.44 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
4.44 | 16675129 14630087 17289903 17261762 12948864 17018787 18497071 19861407 |
MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
4.44 | 18223236 18323546 18234424 16115903 15136595 16273361 11325840 16244791 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
4.44 | 17614352 15562024 16175315 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
4.44 | 19410462 18821012 19011961 18984771 19487384 17242785 21138602 20005174 19221464 18629630 17049068 19200415 18815881 19059307 17893378 19288272 15668708 21152245 15565566 16818667 18351453 19103187 20544844 16273361 17440819 19244106 20135344 18425577 19189210 20390343 18855134 19289846 11161223 17261762 19189212 18997820 16873071 20065188 19084267 16202921 19155303 19142967 19115204 20859285 19066611 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
4.44 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.14 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
16,16-Dimethylprostaglandin E2 |
9.65 | 3786805 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
9.65 | 16124888 16227642 18705752 16192424 3786805 15700767 10355542 16050911 16011737 15721981 16097048 15673190 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.55 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.19 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
10.64 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
10.64 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
10.64 | 16313753 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
10.64 | 16507464 15276417 17306315 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
10.64 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
vinyl carbamate |
10.64 | 12371669 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.66 | 17123778 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
bexarotene |
5.90 | 16247446 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
vinyl carbamate |
5.90 | 16247446 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
4.47 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.47 | 18572023 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.33 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.19 | 16120746 18670907 18850075 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
14.26 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Dinoprostone |
14.26 | 16192471 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
14.26 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
14.26 | 19524636 20056578 |
MESH:D054506 |
Chloracne |
marker/mechanism |
|
| 17101203 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.89 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
6.95 | 17333356 16919318 15861022 16105132 17110522 17681005 11677210 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
6.95 | 19176532 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.43 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
1.97 | 12621046 16354765 15668235 8697196 15340226 |
MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
2.44 | 18802399 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.79 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.24 | 10048152 15322242 20055451 |
MESH:D003456 |
Cryptorchidism |
|
Dibutyl Phthalate |
5.14 | 16037377 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.04 | 19031437 |
MESH:D003876 |
Dermatitis, Atopic |
|
Diethylhexyl Phthalate |
6.46 | 16882537 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
6.46 | 18249437 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.51 | 16285004 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.59 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
7.94 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
7.94 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.17 | 17187935 |
MESH:D003967 |
Diarrhea |
|
Dinoprostone |
4.25 | 7237001 11488427 10446763 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
16,16-Dimethylprostaglandin E2 |
8.23 | 3786805 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
8.23 | 21278145 16227642 7179309 17522070 15027814 4309450 6884620 7440962 15998439 19085960 7120509 19336974 3786805 15968718 2869522 10915739 10092053 9327722 3732212 11566570 6623471 16177239 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
8.23 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.23 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.52 | 11462148 |
MESH:D004381 |
Duodenal Ulcer |
|
16,16-Dimethylprostaglandin E2 |
9.76 | 11595431 10671773 11991626 16699067 |
MESH:D004381 |
Duodenal Ulcer |
|
ONO-AE1-329 |
9.76 | 11991626 11595431 |
MESH:D004417 |
Dyspnea |
|
Furosemide |
4.61 | 16935035 |
MESH:D004487 |
Edema |
|
Furosemide |
14.14 | 11834646 |
MESH:D004487 |
Edema |
|
pirinixic acid |
14.14 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
14.14 | 11000095 12711302 |
MESH:D004487 |
Edema |
|
Zymosan |
14.14 | 7907874 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.57 | 16714409 18230668 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
19.38 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
19.38 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
19.38 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
19.38 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
6.68 | 11473722 18566989 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
6.68 | 19155303 20544844 17893378 16202921 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
8.00 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
8.00 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.37 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
4.37 | 16481741 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.77 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
16.36 | 16239168 19224547 12631006 17595544 15959796 12795759 16045604 61145 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
16.36 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
16.36 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
16.36 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.04 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.14 | 11858732 |
MESH:D005334 |
Fever |
|
Dinoprostone |
4.60 | 16997862 11852909 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.20 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.86 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
7.54 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
7.54 | 20067830 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.35 | 16452187 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.26 | 10696789 |
MESH:D034381 |
Hearing Loss |
|
Furosemide |
4.56 | 17868369 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.16 | 11294989 10048152 |
MESH:D006333 |
Heart Failure |
|
Furosemide |
6.65 | 16011733 16845234 12660669 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
6.65 | 20558911 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.05 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
8.63 | 19900420 19110552 |
MESH:D006505 |
Hepatitis |
|
Zymosan |
8.63 | 19110552 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
7.21 | 16221962 19176532 18467677 19772884 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
7.21 | 15340226 12621046 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.70 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
2.89 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.42 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.71 | 8697196 18606429 15340226 16354765 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Dinoprostone |
4.28 | 16793879 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.21 | 16899240 |
MESH:D006934 |
Hypercalcemia |
|
Furosemide |
4.78 | 17652376 |
MESH:D053565 |
Hypercalciuria |
|
Furosemide |
5.33 | 17652376 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.90 | 20558911 |
MESH:D006962 |
Hyperparathyroidism, Secondary |
|
Furosemide |
5.54 | 15086907 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.78 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.77 | 15338365 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Furosemide |
4.97 | 16612254 |
MESH:C537153 |
Hypomagnesemia primary |
|
Furosemide |
5.33 | 11041285 |
MESH:D007019 |
Hypoproteinemia |
|
Furosemide |
5.54 | 16096441 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.49 | 16945680 16569931 |
MESH:D007022 |
Hypotension |
|
Furosemide |
4.32 | 11041285 |
MESH:D007024 |
Hypotension, Orthostatic |
|
Furosemide |
5.09 | 15811171 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.08 | 15869954 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.16 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
5.92 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
5.92 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
marker/mechanism |
|
| 18287210 |
MESH:D007249 |
Inflammation |
|
Progesterone |
10.58 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
10.58 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
10.58 | 12878042 12200463 |
MESH:D007249 |
Inflammation |
|
Zymosan |
10.58 | 8014878 11289658 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
15.90 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
15.90 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
15.90 | 16306350 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
15.90 | 14714311 |
MESH:D043183 |
Irritable Bowel Syndrome |
|
Zymosan |
5.51 | 17553498 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.05 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
9.15 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Furosemide |
9.15 | 11041285 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
9.15 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
6.52 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
6.52 | 18625569 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.93 | 15342952 17567588 |
MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
4.52 | 17353645 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
2.63 | 11408273 17157831 17174718 11903743 17334410 16239168 16943688 16221502 21278145 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
8.15 | 14748882 15893842 16136751 10355542 16015684 15650968 12389079 15996030 17708605 12958196 14716496 14724832 17698563 14716833 12445418 12632514 14620537 12667390 18277467 15876570 12666154 18156304 14512876 18279442 15052691 17557913 16011737 16033810 15931870 18429990 17823541 12586293 15818738 18412020 18263696 18210741 18317297 12445421 15959796 12741479 18472094 11481614 17976157 17721639 17922224 20821823 18054572 16097048 18006644 17525996 18251166 15123356 18376398 15338365 12649538 16248980 15925388 15673190 17869086 17766677 18472332 17944888 16638106 18420326 17481882 17805973 15370692 15057751 17714472 18705752 17565644 12546737 17761835 18481824 16116963 18339082 18187930 12609069 18205269 15362042 18395095 18418968 17640975 18166357 12898905 12632512 16192424 17631135 16027843 18395914 15730626 13678700 17900296 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dinoprostone |
8.15 | 15816358 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
8.15 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
8.15 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
8.15 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
8.15 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
4.27 | 16964402 15830285 15720792 17285989 16246199 |
MESH:D008107 |
Liver Diseases |
|
Dinoprostone |
4.27 | 15816358 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.85 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.41 | 14706259 16899240 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
16.30 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylhexyl Phthalate |
16.30 | 11940454 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
16.30 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
16.30 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
16.30 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
16.30 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
5.09 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.09 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
2.96 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
bexarotene |
6.15 | 17849452 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
6.15 | 19931552 16712894 15276417 17306315 17077188 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
6.15 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.15 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
vinyl carbamate |
6.15 | 15824018 12117777 15172992 11195469 16885199 16247444 12438228 17163412 12765245 14755239 11134547 17363558 17361011 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
3.76 | 14737004 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
3.83 | 14749477 |
MESH:D016410 |
Lymphoma, T-Cell, Cutaneous |
|
bexarotene |
4.83 | 11161223 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.44 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
bexarotene |
12.58 | 19196722 15591091 19196723 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
12.58 | 16891317 11807958 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
12.58 | 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
12.58 | 16827153 11731420 19196723 14580682 19196722 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
11.54 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
11.54 | 19453300 |
MESH:D008545 |
Melanoma |
|
Paclitaxel |
4.81 | 12025231 12040289 16342250 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
4.81 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
4.81 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.86 | 15990972 |
MESH:D020326 |
Migraine without Aura |
|
Dinoprostone |
4.95 | 11304026 |
MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
3.46 | 14749477 |
MESH:D009102 |
Multiple Organ Failure |
|
Zymosan |
4.91 | 18160304 12879239 12130978 10890648 10479408 15213630 15834315 15241586 15259001 17724436 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.19 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.01 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.76 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.43 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.43 | 16411023 |
MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
5.53 | 15867366 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
5.53 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.41 | 19410462 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
4.40 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
4.40 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.35 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
bexarotene |
9.83 | 19196722 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
9.83 | 19189210 19200415 19196722 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.41 | 17289903 |
MESH:D009397 |
Nephrocalcinosis |
|
Furosemide |
5.54 | 15086907 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
14.56 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
14.56 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
14.56 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
2.93 | 12854658 |
MESH:D053206 |
Nocturnal Enuresis |
|
Furosemide |
5.54 | 17945291 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.73 | 20558911 |
MESH:D010003 |
Osteoarthritis |
|
N-((4-(5,9-diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo(3,4-g)quinolin-7-yl)-3-methylbenzyl)sulfonyl)-2-(2-methoxyphenyl)acetamide |
5.46 | 18287210 |
MESH:D010005 |
Osteoarthropathy, Secondary Hypertrophic |
|
Dinoprostone |
6.14 | 18500342 |
MESH:D010014 |
Osteolysis |
|
Paclitaxel |
4.65 | 15867366 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.66 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
10.42 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
10.42 | 11161223 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
10.42 | 16525653 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
10.42 | 15276417 17306315 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.39 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.92 | 12520081 |
MESH:D010538 |
Peritonitis |
|
Zymosan |
4.57 | 14761945 15979727 18760300 19641140 18557954 18977430 11985352 17371808 15259001 17826846 19088179 |
MESH:D010954 |
Plasmacytoma |
|
pristane |
6.96 | 15087411 |
MESH:D011141 |
Polyuria |
|
Furosemide |
5.33 | 17945291 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.25 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
8.42 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.42 | 11118676 11222880 11896295 11399792 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.45 | 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
9.58 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
9.58 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.05 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
2.05 | 18247401 15754350 16289102 12479363 16644109 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.05 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
2.05 | 16729912 17136230 17172428 16356831 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.05 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
2.05 | 18760546 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.05 | 15067354 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.99 | 15861022 16919318 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.46 | 10548101 |
MESH:D015427 |
Reperfusion Injury |
|
Furosemide |
6.26 | 16526316 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
6.26 | 19058328 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Furosemide |
4.32 | 15912074 16096441 12394941 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.53 | 18990726 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.74 | 18045962 |
MESH:D018805 |
Sepsis |
|
Zymosan |
4.38 | 11441115 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
5.07 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.07 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
10.46 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
10.46 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
9.79 | 16503802 15862959 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
9.79 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.55 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Furosemide |
2.98 | 17052386 |
MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
2.98 | 18506536 18396642 |
MESH:D013276 |
Stomach Ulcer |
|
16,16-Dimethylprostaglandin E2 |
4.94 | 11595431 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.66 | 16045194 16684133 |
MESH:D024801 |
Tauopathies |
|
Paclitaxel |
4.49 | 16930453 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.32 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.88 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.57 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.35 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
4.68 | 16712894 11723127 17306315 16452187 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
4.68 | 16712894 17572228 8653321 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.49 | 11813266 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.68 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
2.99 | 14692618 |
MESH:D014605 |
Uveitis |
|
Zymosan |
5.07 | 11006244 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.10 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.26 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.25 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.92 | 15886252 |